跳至主要内容
临床试验/NCT00483808
NCT00483808已完成1 期

Renal Denervation in Patients With Refractory Hypertension

Medtronic Vascular5 个研究点 分布在 2 个国家目标入组 73 人开始时间: 2007年6月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
73
试验地点
5
主要终点
To provide confirmation that renal denervation is safe and feasible.

研究概览

简要总结

To investigate the clinical utility of renal denervation in the treatment of refractory hypertension.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >= 18 years of age.
  • a systolic blood pressure of 160 mmHg or greater.
  • receiving and adhering to full doses of an appropriate antihypertensive drug regimen for a minimum of two weeks prior to screening.
  • agrees to have the study procedure(s) performed and additional procedures and evaluations, including repeat phlebotomy, imaging, urine analyses, and clinical examination.
  • competent and willing to provide written, informed consent to participate in this clinical study.

排除标准

  • renal arterial abnormalities
  • end stage renal disease requiring dialysis or renal transplant
  • serum Cr > 3, or calculated GFR < 45 ml/min
  • has experienced MI, unstable angina pectoris, or CVA with 6 months

结局指标

主要结局

To provide confirmation that renal denervation is safe and feasible.

时间窗: 3 years

次要结局

  • Evidence of renal denervation; indication of physiologic response; assessment of device performance.(3 years)

研究者

发起方
Medtronic Vascular
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验